Clinical practice consensus for the diagnosis and management of melanoma in Taiwan

Chiao En Wu, Yi Hua Liao, Cheng Lin Wu, Ruoh Fang Yen, Chia Chi Lin, Muh Hwa Yang, Chueh Chuan Yen, Wu Chou Su, Chia Jui Yen, Yi Fang Chang, Ming Fang Wu, Youngsen Yang, Chen Yuan Lin, Wen Chi Yang, Hui Ching Wang, Cheng Yuan Li, Yin Yu Ho, Yao Yu Chang, Chieh Shan Wu, Hsiu Cheng HsuKuang Hua Chen, Yenlin Huang, Chih Jung Chen, Pei Ju Chuang, Yung Chi Lai, Yu Yi Huang, Neng Chuan Tseng, Yi Ting Huang, Chia Yu Chu*, John Wen-Cheng Chang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

3 Scopus citations


Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence.

Original languageEnglish
Pages (from-to)7-15
Number of pages9
JournalJournal of the Formosan Medical Association
Issue number1
StatePublished - 01 2024

Bibliographical note

Copyright © 2023. Published by Elsevier B.V.


  • Acral melanoma
  • Immunotherapy
  • Melanoma
  • Mucosal melanoma
  • Targeted therapy
  • Humans
  • Taiwan
  • Melanoma/diagnosis
  • Consensus
  • Skin Neoplasms/diagnosis


Dive into the research topics of 'Clinical practice consensus for the diagnosis and management of melanoma in Taiwan'. Together they form a unique fingerprint.

Cite this